gabapentin
Generic: gabapentin
Labeler: rising pharma holdings, inc.Drug Facts
Product Profile
Brand Name
gabapentin
Generic Name
gabapentin
Labeler
rising pharma holdings, inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
gabapentin 400 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
16571-869
Product ID
16571-869_2e493243-47c0-460e-bea9-4ed0261adf90
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA207099
Listing Expiration
2026-12-31
Marketing Start
2022-08-01
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
16571869
Hyphenated Format
16571-869
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
gabapentin (source: ndc)
Generic Name
gabapentin (source: ndc)
Application Number
ANDA207099 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 400 mg/1
Packaging
- 100 CAPSULE in 1 BOTTLE (16571-869-01)
- 30 CAPSULE in 1 BOTTLE (16571-869-03)
- 1000 CAPSULE in 1 BOTTLE (16571-869-10)
- 500 CAPSULE in 1 BOTTLE (16571-869-50)
Packages (4)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2e493243-47c0-460e-bea9-4ed0261adf90", "openfda": {"nui": ["N0000008486"], "unii": ["6CW7F3G59X"], "rxcui": ["310430", "310431", "310432"], "spl_set_id": ["969cccfc-e56a-49da-9d36-47c0c3fad7f8"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (16571-869-01)", "package_ndc": "16571-869-01", "marketing_start_date": "20220801"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (16571-869-03)", "package_ndc": "16571-869-03", "marketing_start_date": "20220801"}, {"sample": false, "description": "1000 CAPSULE in 1 BOTTLE (16571-869-10)", "package_ndc": "16571-869-10", "marketing_start_date": "20220801"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (16571-869-50)", "package_ndc": "16571-869-50", "marketing_start_date": "20220801"}], "brand_name": "gabapentin", "product_id": "16571-869_2e493243-47c0-460e-bea9-4ed0261adf90", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "16571-869", "generic_name": "gabapentin", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "400 mg/1"}], "application_number": "ANDA207099", "marketing_category": "ANDA", "marketing_start_date": "20220801", "listing_expiration_date": "20261231"}